Newamsterdam Pharma Co. NV – Investors and Politicians Who Own It
NAMS, 2 share classes and securities
Investors who own it
9 tracked investors, $749.3M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Peter KolchinskyRA Capital Management, Q2 2026 | $323.7M | 2.81% |
Andreas HalvorsenViking Global Investors, Q2 2026 | $142.5M | 0.41% |
Lee AinslieMaverick Capital, Q2 2026 | $110.7M | 0.98% |
Stanley DruckenmillerDuquesne Family Office, Q2 2026 | $104M | 2.00% |
Castle Hook PartnersQ2 2026 | $46.5M | 0.21% |
Joseph EdelmanPutPerceptive Advisors, Q2 2026 | $16.9M | 0.25% |
David GreenspanSlate Path Capital, Q2 2026 | $10.8M | 0.15% |
Peter KolchinskyRA Capital Management, Q2 2026 | $7.1M | 0.06% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $4M | 0.18% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Stanley Druckenmiller | Added +60% | 3,070,146 |
| Peter Kolchinsky | Reduced −5.8% | 9,550,191 |
| Castle Hook Partners | New | 1,085,008 |
| Andreas Halvorsen | Reduced −35% | 4,203,567 |
| Lee Ainslie | Added +26% | 1,894,226 |
| Daniel Schneeberger | Added +3.7% | 118,623 |
| Polen Capital | New | 11,239 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.